Fusion Capital, LLC Eli Lilly & CO Transaction History

Fusion Capital, LLC

$224 Million
Q3 2024

A detailed history of Fusion Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fusion Capital, LLC holds 1,405 shares of LLY stock, worth $1.06 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

1,405

Previous 1,404 0.07%

Holding current value

$1.06 Million

Previous $1.27 Million 2.12%

% of portfolio

0.56%

Previous 0.58%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $772 - $960	1 Added 0.07%	1,405 $1.24 Million
Q2 2024 Aug 06, 2024	SELL	$724.87 - $909.04 $108,005 - $135,446	-149 Reduced 9.59%	1,404 $1.27 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $1,184 - $1,584	2 Added 0.13%	1,553 $1.21 Million
Q4 2023 Jan 22, 2024	SELL	$525.19 - $619.13 $130,247 - $153,544	-248 Reduced 13.79%	1,551 $904,000
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $7.63 Million - $10.2 Million	-21,764 Reduced 92.37%	1,799 $843,000
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $392,325 - $460,767	-1,263 Reduced 5.09%	23,563 $8.09 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $119,938 - $139,751	-373 Reduced 1.48%	24,826 $9.08 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $248,746 - $283,472	-839 Reduced 3.22%	25,199 $8.15 Million
Q2 2022 Jul 13, 2022	BUY	$278.73 - $327.27 $39,300 - $46,145	141 Added 0.54%	26,038 $8.44 Million
Q1 2022 May 03, 2022	BUY	$234.69 - $291.66 $195,496 - $242,952	833 Added 3.32%	25,897 $7.42 Million
Q4 2021 Jan 12, 2022	BUY	$224.85 - $279.04 $204,163 - $253,368	908 Added 3.76%	25,064 $6.92 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $115,232 - $141,809	520 Added 2.2%	24,156 $5.58 Million
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $139,926 - $180,993	775 Added 3.39%	23,636 $5.43 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $44,859 - $58,072	-273 Reduced 1.18%	22,861 $4.27 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $160,204 - $211,989	1,228 Added 5.61%	23,134 $3.91 Million
Q3 2020 Nov 06, 2020	SELL	$146.22 - $169.13 $124,140 - $143,591	-849 Reduced 3.73%	21,906 $3.24 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $4,911 - $5,910	36 Added 0.16%	22,755 $3.74 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $188,575 - $233,402	-1,584 Reduced 6.52%	22,719 $3.15 Million
Q4 2019 Feb 24, 2020	BUY	$106.92 - $132.43 $2.6 Million - $3.22 Million	24,303 New	24,303 $3.19 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $717B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fusion Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fusion Capital, LLC with notifications on news.

Account

Fusion Capital, LLC Eli Lilly & CO Transaction History